Specialty medicines are increasingly being released into the market and it’s vital to ensure that patients adhere to the prescribed treatment to remain safe and healthy. RxMx’s Chameleon -- built on InterSystems IRIS for Health® -- features a configurable platform and a suite of apps to support the unique needs and challenges facing specialty medicines. The platform easily integrates with a variety of data sources to launch and support these drugs around the world.

Join this webinar to learn:
  • How the team has developed a variety of products to support solutions ranging from managing COVID-19 test data to keeping MS patients on track for scheduled infusions.
  • Why regulators and pharma companies need to mitigate risk and implement patient adherence strategies for so many new specialty therapeutics.
  • The role of digital adherence monitoring, analysis and intervention, in pharmaceutical development and commercialization, as illustrated by the experience of the RxMx team.
  • How a data management platform designed for healthcare application development helps RxMx deliver on its promise of an agile technology solution.

Featured Speakers

Tessa Angle

Director of Americas

Tessa leads operations for RxMx across the Americas. Since joining RxMx as the first U.S. employee, Tessa created the U.S. business by recruiting, developing and leading the U.S. team and portfolio. Before joining RxMx, Tessa worked for leading pharmaceutical firms, Sanofi and Bayer, as a health economist in France and Australia, developing market access strategies for the reimbursement of new therapies. She then pivoted her data-driven approach to developing, launching and optimizing patient support programs and patient education at Atlantis Healthcare, a behavioral-based intervention solution provider and Ogilvy CommonHealth.

Matt Smallcomb

Head of Product

Matt is an experienced product leader who specializes in driving vision and roadmap for products that support health care providers, patients and operational teams. He focuses on collaboration with cross-functional partners to deliver successful results. He has worked on a number of healthcare products including patient support programs, EHRs, practice management tools and a suite of patient engagement apps. Prior to entering the product and healthcare space, Matt worked as an engineer and researcher in the aerospace and experimental physics fields.

Matthew Stannard

Life Sciences Advisor

Matthew is a drug and device development professional with more than twenty years of multinational experience spanning the many facets of discovery, development and patient access. He began his career in the laboratory, moving to patient-focused clinical development, and then leadership roles in Business Development & Licensing. Matthew’s most recent venture was a game-changing digital health technology startup where he led business and corporate development, forging industry collaborations to help patients with unmet medical needs secure access to otherwise inaccessible treatment options. Matthew is an Entrepreneur-in-Residence at Yale University, Angel Investor and Screening Committee Member for the Angel Investor Forum of Connecticut.

Now Available On-Demand